Why is Meghmani Organi. falling/rising?

Recent Price Movement and Market Performance

Meghmani Organics’ share price has been under pressure over the past week, declining by 6.16%, significantly underperforming the Sensex, which remained almost flat with a marginal 0.06% gain. The stock’s one-month performance is even more concerning, with a 16.18% drop compared to the Sensex’s 0.82% rise. Year-to-date, the stock has lost 11.91%, while the benchmark index has gained 8.65%. Over the last year, the stock’s decline is more pronounced at 26.67%, contrasting sharply with the Sensex’s 7.31% appreciation. This underperformance extends over three years, where Meghmani Organics has lost over 40%, while the Sensex has surged by more than 36%.

On the day of the decline, the stock underperformed its sector by 1.92%, reversing gains made over the previous two days. Intraday, it touched a low of ₹67.19, down 3.74%, with heavier trading volume concentrated near this low price, signalling selling pressure. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a bearish technical trend. Additionally, investor participation appears to be waning, with delivery volumes on 21 Nov falling by 5.54% compared to the five-day average, suggesting reduced conviction among buyers.

Fundamental Strengths Amidst Price Weakness

Despite the recent price weakness, Meghmani Organics has reported encouraging operational results. The company has posted positive earnings for five consecutive quarters, with the latest quarterly profit after tax (PAT) reaching ₹11.55 crores, representing a remarkable 145.2% growth compared to the previous four-quarter average. Net sales for the latest six months stood at ₹1,190.88 crores, up 24.34%, reflecting robust revenue expansion. The company’s return on capital employed (ROCE) for the half-year is at a peak of 7.30%, while the trailing ROCE is 4.6, indicating an attractive valuation relative to capital employed. The stock trades at a discount to its peers’ historical valuations, supported by a low PEG ratio of 0.3, which suggests that the stock’s price does not fully reflect its profit growth potential.

Long-Term Challenges and Investor Concerns

However, these positives are overshadowed by significant long-term fundamental weaknesses. Meghmani Organics has experienced a negative compound annual growth rate (CAGR) of -18.02% in operating profits over the past five years, signalling deteriorating core profitability. The company’s average return on equity (ROE) is a modest 6.03%, indicating limited efficiency in generating profits from shareholders’ funds. This low profitability metric raises concerns about the company’s ability to deliver sustainable shareholder value.

Investor confidence appears to be waning, particularly among institutional investors who have reduced their stake by 0.83% in the previous quarter, now collectively holding only 1.52% of the company. Institutional investors typically possess superior analytical resources and tend to exit positions when fundamentals weaken, which may be contributing to the stock’s downward pressure. The stock’s underperformance relative to the BSE500 index over one year, three years, and the recent three months further underscores its struggles to keep pace with broader market and sector peers.

Conclusion: A Complex Picture for Investors

Meghmani Organics’ share price decline on 24-Nov reflects a market grappling with mixed signals. While the company’s recent earnings growth and attractive valuation metrics offer some optimism, the persistent long-term decline in operating profits, low return on equity, and reduced institutional interest weigh heavily on investor sentiment. The stock’s technical weakness and underperformance relative to benchmarks suggest caution for investors, despite the company’s operational improvements. As such, Meghmani Organics remains a stock characterised by fundamental challenges that continue to suppress its market valuation.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →